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ASSOCIATION OF TYPE AND SEVERITY OF NONSYNDROMIC OROFACIAL CLEFTS
WITH COMBINED GENOTYPES OF RFC1 80 GA, MTHFR 677 CT, IRF6 rs642961 AND
rs2235371 GENE POLYMORPHISMS IN AN INDIAN POPULATION

Abstract

By Chantal Hakim
University of the Pacific. Arthur Dugoni School of Dentistry
2020

Introduction. Genetic etiology of nonsyndromic orofacial clefts comprises many genes acting
together. However, little is known about their interactions. The purpose of our study was to
analyze associations of phenotypic subtypes of nonsyndromic orofacial clefts with combinations
of four genotypes involving candidate gene polymorphisms.
Materials and Methods. We analyzed a large dataset of cases and controls collected in one
location (Karaikal in India) and genotyped for four gene polymorphisms: RFC1 G80A, MTHFR
C677T, IRF6 GA rs642961 and IRF6 CT rs2235371 (IRB approval Nr. 17-118 for existing data).
The samples were tested for Hardy-Weinberg genetic equilibrium. Combinations of genotypes in
cleft subsamples were compared with controls using Odds Ratio and Confidence Interval (95%
significance level) calculations.
Results. The Hardy-Weinberg equilibrium test showed that all samples were in genetic
equilibrium. Some combinations of RFC1 G80A, MTHFR C677T, IRF6 GA rs642961 and IRF6
CT rs2235371 yielded increased or decreased Odds Ratio (OR>1 or OR<1).This means that
subtypes of orofacial clefts were differentially determined by genotype combinations of four
gene polymorphisms.
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Conclusions. Our results suggest that combinations of gene polymorphisms may modulate
genetic risk in subtypes of nonsyndromic orofacial clefts. Such studies seem to be important for
development of a general procedure and how a prevention plan for a specific location needs to be
prepared, which data needs to be collected and which analyses need to be performed.
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PART I.
General Introduction

CHAPTER 1

Purpose, Hypothesis and Specific Aims
The purpose of our study was to analyze associations of phenotypic subtypes of
nonsyndromic orofacial clefts with combinations of four genotypes involving candidate gene
polymorphisms. We were able to do this by utilizing the rather large dataset of cases and
controls, all from one specific location, genotyped for four gene polymorphisms.
Analysis of combinations of eight alleles of four genes in one genotype and possible
associations of unique combined genotypes with different types of cleft required a specific
analytic approach. It was important to take into consideration that not all 81 possible
combinations were found among cases and controls in our study. Even though we may have
increased the size of a phenotypic subsample, we avoided merging unique combined genotypes
as much as possible as it may have masked an association with a specific type of cleft.

Our null hypothesis states that there are no specifically different combinations of
polymorphisms of four genes selected for our study (RFC1 80 GA, MTHFR 677 CT, IRF6
rs642961, and IRF6 rs223537) in subgroups of cases with different types of clefts.

The alternative hypothesis states that such differences do exist.
To prove or reject our hypotheses, we started with looking at each of these genes separately and
then at their combinations.
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Specific aims:
1. Establish presence of Hardy-Weinberg equilibrium in our subsamples of cases and in
controls
2. Calculate OR and CI for genetic risk evaluation (risk based on genetic background of
four gene polymorphisms studied)

The sequence of analysis was as follows:
1. Polymorphism of RFC1 80GA in categories by types of clefts and in controls
2. Polymorphism of MTHFR 677CT in categories by types of clefts and in controls
3. Combined genotypes of RFC1 80GA + MTHFR 677CT + IRF6 rs642961 + IRF6
rs2235371 in categories by types of clefts and in controls
3.1. Testing of Hard-Weinberg equilibrium in subcategories by types of cleft
and in controls
3.2. Odds Ratio and Confidence Interval (95% significance level) comparisons
of combined genotypes in subcategories of clefts with the same combined genotypes
in controls
3.2.1. One mutated gene allele in combined genotype
3.2.2. Two mutated gene alleles in combined genotype
3.2.3. Three mutated gene alleles in combined genotype
3.3. Proportion of combined genotypes with mutated alleles in all four genes
and combined genotypes with no mutations in cases and in controls
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CHAPTER 2

Background Information
2.1. Definition, prevalence, and classification of orofacial clefts
Orofacial clefts (OFC) are a diverse group of congenital anomalies. They encompass “typical”
orofacial clefts, which include cleft lip (CL), cleft lip and palate (CLP), and cleft palate (CP), as
well as “atypical” clefts, which include median, transversal, oblique and other types of rare
clefts. Both typical and atypical orofacial clefts can occur as isolated anomalies (non- syndromic
- NCL/P), or as a part of a sequence or syndrome (Tolarova and Cervenka, 1998). There have
been over 400 syndromes recognized, which may include orofacial clefts as one of the
manifestations. Some of the common syndromes and/or anomalies associated with clefting
include Apert, Meckel, Treacher Collins, and van der Woude syndromes (Radhakrishna, 2006).
The majority of orofacial clefts (70%) are non-syndromic.
Cleft lip and palate is one of the most common congenital anomalies affecting 1 in every 5001000 births worldwide (Tolarova and Cervenka, 1998). The prevalence rates vary between 0.5
and 3 per 1000 total births, with considerable variations between populations, genders and
geographic regions (The International Centre for Birth Defects, 2003). The highest birth
prevalence of orofacial clefts is observed in the Asian and American Indian populations often
reaching 1 in every 500 births, while in Caucasian populations is intermediate and African
populations have the lowest at 1 in 2500 births (Murray, 2002).
2.2. Embryology of cleft lip and palate
The development of the face occurs through the coordination of complex morphogenetic events
and rapid proliferative expansion. As a result, it is highly susceptible to malformations due to
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environmental or genetic causes. Cleft lip (CL) results from the failure of merging between the
medial nasal and maxillary processes at the fifth week of embryonic development. Cleft lip can
be unilateral or bilateral. If the cleft lip impairs the subsequent fusion of palatal shelves, it can
be accompanied by cleft palate (CP), thus forming a cleft lip and palate (CLP). Cleft palate only
(CP or CPO) results from partial or total lack of fusion of the palatal shelves. This may occur
due to defective growth of the palatal shelves, failure of the shelves to attain a horizontal
position, lack of contact between the shelves, or rupture after fusion. (Figure 2.1.).

Figure2.1. Embryology of cleft lip and/or palate

The normal fusion of the palatal shelves typically begins in the 8th week and continues usually
until the 12th week of fetal life (Ten Cate 2003, Tolarova 2011). Clinical presentation of
orofacial clefts – cleft lip on the left side (CL left), cleft lip on the right side (CL right), cleft lip
on both sides (CL bi), cleft lip and palate on the left side (CLP left), cleft lip and palate on the
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right side (CLP right), cleft lip and palate on both sides (CLP bi), and cleft palate only (CP or
CPO) are diagnosed at birth (Figure 2.2.).

Cleft Lip (CL uni)

Cleft Lip (CL uni)

(CP)

(CLP uni)

Cleft Lip (CL bi)

(CLP bi)

Figure 2.2. Examples of various types of “typical” orofacial clefts

2.3. Etiology of cleft lip and/or palate
The etiology of orofacial clefts is complex and still not completely understood. Researchers
believe that most cases of NCL/P are of a multifactorial etiology, caused by an interaction
between genes and the environment. (Figure 2.3) Evidence suggests that while genetic factors
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create susceptibility for clefts, environmental factors trigger the development of clefts through
their interaction with susceptible genotypes.
It is estimated that 25% of congenital anomalies are due to genetic causes, 10% are caused by
environmental factors and 65% result from a combination of genetics and environmental factors
(Tolarova, 2011; Figure 2.3.).

Figure 2.3. Etiology of cleft lip and palate anomalies (Tolarova, 2011)

The multifactorial threshold model of liability (MF/T) has been suggested to explain the etiology
of NCL±P as the cumulative effects of a number of combined genetic and environmental factors
that add up and result in the formation of a cleft once a threshold is reached.
There are four categories of thresholds based on the sex of the individual and the severity of the
type of cleft: unilateral clefts in males have the lowest threshold and bilateral clefts in females
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have the highest (Tolarova, 1990). Numerous environmental factors may play a role in cleft
development. Some of these factors include: nutritional deficiencies including folic acid,
teratogens, maternal hypoxia, and common environmental exposures, such as maternal alcohol or
cigarette use, herbicides, and high altitude (Murray, 2002). Many inheritance patterns have been
suggested in the past, however, the complex inheritance patterns that have been observed in
recent studies support the idea that the heritability of NCL/P is affected by several genes
(Wyszynski et al., 1996). Prevention of NCL/P relies on reduction or elimination of
environmental insults with a hope that genetic factors alone are not strong enough to carry an
individual over the threshold.
2.4. Cleft lip and/or palate in India
The sub-continent of India is one of the most densely populated areas in the world with an
estimated population of 1.1 billion people. It is difficult to obtain a reliable and complete record
of statistics regarding prevalence of OFC in India due the country’s infrastructure. The number
of newborns with orofacial clefts in India has been estimated to be somewhere between 27,000
and 35,000 per year. A three-center study conducted in Baroda, Delhi and Mumbai in 19941996 found that 28,600 infants per year were born with CL/P, which means 78 affected infants
are born every day or 3 infants with clefts are born every hour (Mossey and Little, 2009).
Another study conducted in 2012 by Dvivedi and Dvivedi, investigated the clinical and
demographic profile of cleft lip and palate in Sub-Himalayan India. This prospective cohort
observational case series was performed on 4,657 patients with an orofacial cleft over a 5 year
period at a tertiary care hospital in Dehradun, India, which is approximately 900 km to the
northeast of Udaipur. They found that the majority of patients were from a low socioeconomic
class; 60.58% had family earnings of less than 1000 rupees per month, whereas the government
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identified “poverty line” is considered to be below 1750 rupees per month. Seventy-two percent
of parents of patients with CL/P were illiterate and only 8% were graduates. One percent of the
cleft patients had siblings with similar deformities. Anemia was seen in 83.16% of cases
(microcytic hypochromic type was most common), and eosinophilia was seen in 25.5% of cases.
Approximately 93% of the families reported that they were fully satisfied with the treatment
rendered and results achieved at this hospital (Dvivedi and Dvivedi, 2012).
It is known that in many parts of India, especially in the small villages and rural areas, the
parents of children born with a cleft do not have access to counseling on the care and treatment
of their child. In ancient times, clefts were presumed to be a curse of God. This same belief is
often still held in many of these remote, rural areas of India. Children born with these
deformities are frequently called “Khandu,” meaning incomplete (Dvivedi and Dvivedi, 2012).
Inequalities exist in urban versus rural access to and quality of cleft care. Over the years there
has been a backlog of 1 million unrepaired clefts of the lip and palate in India, which has created
a significant health care problem. In recent years, the situation has been considerably improved
by The Smile Train, Interplast, Rotaplast International, and other Non-Governmental
Organizations (Mossey and Little, 2009).
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PART II
Association of type and severity of nonsyndromic orofacial clefts cleft lip with
combined genotypes of RFC1 80GA, MTHFR 677CT, IRF6 (rs642961) and
IRF6 (rs2235371) gene polymorphisms in an Indian population

CHAPTER 3

Introduction and Literature Review
3.1. Genetics of cleft lip and/or palate
In recent years, there has been considerable interest in identifying genes that contribute to
the etiology of orofacial clefting. A number of genes have been found to play a role in the
development of orofacial clefts, however, much of this information is still incomplete. Some
genes which have been found to be associated with CL/P include MTHFR, RFC1, MSX1, TGFα,
TGFβ3, IRF6 (Tolarova, 2018).
There have been many studies that have researched the correlation between bioavailability of
folate and NCL/P. Genes coding for folate-metabolizing enzymes are candidate genes for NCL/P
based on data showing that folic acid supplementation could reduce the occurrence of clefting.
Folate, a water-soluble vitamin B9, is necessary for the body to undergo cell multiplication,
differentiation, and maintenance. These cell processes are especially essential during pregnancy
to allow the fetal cells to undergo growth and DNA replication (Vieira, 2005). Folic acid
supplementation is known to decrease risk for neural tube defects and has been also found to
decrease the recurrence (Tolarova, 1982; Tolarova and Harris, 1995) and the occurrence (Shaw
et al, 1995) of NCL±P, because facial mesenchyme is derived from the same cells important for
neural tube closure. Abnormalities in folic acid metabolism may adversely affect critical stages
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of embryonic development and may lead to the development of NCLP.
Methylenetetrahydrofolate reductase (MTHFR) and reduced folate carrier 1 (RFC1) are
candidate genes for NCL±P due to their role in folate metabolism and uptake.
Recently, Velazquez (Velázquez-Aragón et al, 2012) published a study that identified statistically
significant interactions between the 8q24 region and maternal folic acid intake. Cases with a
mutated homozygote genotype on the 8q24 chromosome who did not take folic acid were at
significantly increased risk of NSCL/P (OR of 4.5). In a variant-variant analysis done in the
same study, IRF6 was found to significantly interact with 8q24 variants. Other studies have
identified similar gene-gene interactions between the 8q24 regions and IRF6 (Blanton et al.
2010). This ultimately supports the interrelationships of these loci with folate intake. MTHFR
and RFC 1 are both genes whose mutations can disrupt the transport and processing of folic acid.
Studying polymorphism of RFC1, MTHFR and IRF6 genes in combination may give us a better
understanding of the complex gene interactions involved and a marriage of genetic and
environmental factors involved in the etiology of cleft lip and palate.
3.2. Characteristics of RFC1 80GA gene polymorphism
The Reduced Folate Carrier 1 (RFC1) gene is located on the chromosome 21 long (q) arm at
position 22.3 and it is 27,714 base pairs in length (Figure 3.1.).

RFC1

Figure 3.1. Reduced Folate Carrier 1 (RFC1), located on the long (q) arm
chromosome 21 at position 22.3
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The function of the gene is to code for a protein involved in carrier-mediated transport of folate
across the cell membrane. There are several known mutations of the RFC1 gene including the
polymorphism at the nucleotide 80 (80GA). The Human Gene nomenclature database symbol is
SLC19A1 or solute carrier family 19 folate transport member 1 and aliases including Folate
Transporter (FOLT) and Intestinal Folate Carrier 1 (IFC1). In the RFC1 80GAG polymorphism,
the nucleotide guanine (G; wild allele) is replaced by adenine (A; mutated allele) at nucleotide
position 80. This missense mutation results in a substitution of glutamine (CGG)) with an
arginine (CAG) in the protein (Delurgio, 2009).
3.3. Characteristics of MTHFR 677CT gene polymorphism
Methylenetetrahydrofolate reductase (MTHFR) is located on the short arm of chromosome
1 (1p36.3). The MTHFR gene has a cDNA sequence that is 2.2 kilobases long and codes for
a catalytically active 77 kDa protein (Figure 3.2.).

MTHFR

Figure 3.2. Methylenetetrahydrofolate reductase (MTHFR) gene, located on the short (p)
arm of Chromosome 1 at position 36.3

5, 10-methylenetetrahydrofolate reductase (MTHFR) is an important enzyme in folate
metabolism. It converts 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the
predominant circulating form of folate, which is then used to convert homocysteine to
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methionine. The point mutation at the 677th position of MTHFR gene, which replaces cytosine
(C) with thymine (T), generates an amino acid substitution of valine for alanine. The MTHFR
677 CT missense mutation converts alanine to valine at the position 222. This makes the
MTHFR thermolabile and reduces its enzyme activity to 65% of normal in 677 CT heterozygotes
and to 30% of normal in 677 TT homozygotes. Thus, the 677CT mutation is associated with
lowered plasma folate and elevated plasma homocysteine levels due to reduced MTHFR activity
(Delurgio, 2009).
3.4. Characteristics of IRF6 rs642961 and IRF6 rs2235371 Gene Polymorphisms
3.4.1 Gene characteristics of IRF6
IRF6 gene variants, also known as single nucleotide polymorphisms (SNPs), play a role
in the genetic etiology of Van der Woude and Popliteal Pterygium syndromes, as well as in
etiology of nonsyndromic cleft lip and/or palate. The interferon regulatory factor 6 gene encodes
the IRF6 protein which is a part of the interferon regulatory transcription factor family. This
transcription factor plays a major role in early development, formation of connective tissue, and
epithelial cell proliferation.
In terms of its cytogenetic location, the IRF6 gene is located at 1q32.2, the long (q) arm of
chromosome 1 at position 32.2. Its molecular location is in base pairs 209,785,623 to
209,806,175 on chromosome 1 (IRF6 Gene, 2008). As mentioned above, mutations in IRF6
contribute to both the syndromic and nonsyndromic cleft lip/and or palate, and thus this gene is
of importance to orofacial clefting studies. Specifically, if certain single nucleotide
polymorphisms are found to be associated with NCL/P in a population, this may ultimately
enhance the ability to identify those at a higher genetic risk of having children with NCL/P.
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Figure 3.3. Interferon regulatory factor 6 (IRF6) gene located on the long (q) arm
of chromosome 1 at position 32.3
3.4.2. IRF6 and cleft lip and/or palate
Out of all of the genes studied, the strongest association with nonsyndromic cleft lip and/or
palate has been demonstrated for the IRF6 gene (Zucchero et al. 2004). Molecular studies have
been conducted to determine the extent of the association of the IRF6 gene and nonsyndromic cleft
lip and palate in various populations. Dierks (Dierks et al. 2009) identified 3 candidate single
nucleotide polymorphisms (SNPs) within IRF6 that are significantly associated with
nonsyndromic cleft lip and palate in a Honduran population in 2009. Scapoli (Scapoli et al. 2005)
found that polymorphisms at the IRF6 locus were strongly linked to nonsyndromic cleft lip with
or without cleft palate in an Italian population. Genetic variants in the IRF6 gene were associated
with orofacial clefts in a Norway population in 2008 by Jugessur (Jugessur et al. 2008). In central
European patients, IRF6 gene variants were also connected to nonsyndromic cleft lip and palate
by Birnbaum in 2009 (Birnbaum et al. 2009). Finally, IRF6 polymorphisms were affiliated with
nonsyndromic orofacial clefts in a Chinese Han population in 2010 by Pan (Pan et al. 2010). These
studies illustrate that across numerous populations and ethnicities, IRF6 gene variants contribute
to the etiology of nonsyndromic cleft lip and palate.
Numerous populations from various countries have established a connection between single
nucleotide polymorphisms in the IRF6 locus and nonsyndromic cleft lip and palate. Recently a
study of IRF6 variants was conducted in the Indian populations from the southern regions of
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Puducherry and Karnataka (Stepanek 2019). Two SNPs were analyzed. For the first SNP,
rs642961 G/A, statistically significant differences were found between allele frequencies when
comparing the genotypes CL and CLP, where allele A was found in a greater percentage in the
CL genotype. Results of this study suggested that different cleft phenotypes may be associated
with the specific gene variant IRF6 rs64261 GA, and thus it may play a role in the genetic
susceptibility for OFC. Results of the second variant (IRF6 rs2235371 CT) suggested that
different cleft phenotypes may not be associated with the specific gene variant IRF6 rs2235371
and thus it may not influence the genetic susceptibility for orofacial clefts in the Indian
population. From this study we were left with the need for a better understanding the complex
role of IRF6 variants in OFC and help provide specific risk estimates in specific populations.
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CHAPTER 4

Materials and Methods

Existing data was analyzed (IRB approval Nr. 17-118). For both variants of IRF6 gene (IRF6
rs642961, IRF6 rs2235371) we used data from Christine Stepanek’s MSD thesis.
4.1. Sample characteristics
Modeling the set of criteria developed by previous studies, data was gathered from the
town Karaikal of the Indian union territory of Puducherry during the Rotaplast cleft medical
mission in 2005, effectively constituting a data set with a well-defined population and a specific
time period.

Table 4.1.
Sample characteristics of case on control samples used for analysis of combined
genotypes of RFC1 80 GA, MTHFR 677 CT, IRF6 rs642961, and IRF6 rs2235371

A total of 317 individuals were included in the study of combined genotypes (Table 4.1). All
underwent a physical exam, blood sample draws, and surveys regarding medical history, family
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history, and mother’s diet. Out of them 140 were controls and 177 individuals were affected
with nonsyndromic cleft lip with or without cleft palate (CL, CLP, and CP). Individuals
included in the control group, had no orofacial clefts, craniofacial congenital anomalies, or
developmental syndromes, and no relative (s) in the family were affected with cleft or other
congenital anomaly. They were all from the same hospital as patients with cleft, and came either
for routine blood draw follow-up or were hospitalized at surgery ward for trauma.
For evaluation of genotypes and alleles of single genes we have available more cases and
controls specimens. For analysis of RFC1 80 GA there were 164 controls and 229 cases (Table
5.1) and for analysis of MTHFR 677 CT there were 153 controls and 179 cases (Table 5.5.)
4.2 Location Characteristics
As mentioned previously, the subjects included in the study came from the town Karaikal
of the Indian union territory of Puducherry. A review of the specific location characteristics is
necessary in order to understand the environmental and lifestyle variables that may serve as
confounding or contributing factors for the presence, pattern, and genetic foundation of the cleft
lip and palate anomaly of our subject population.
Puducherry, formerly known as Pondicherry, is a union territory of India located in the
south-eastern part of the Indian peninsula. It is composed of 4 small unconnected districts:
Puducherry district (293 km2), Karaikal district (161 km2), Yanam district (20 km2), and Mahé
district (9 km2). The culture of Karaikal reflects a strong French influence, as it became a colony
of the French colonial empire in 1674 before being transferred to the Republic of India in 1954.
Of all the union territories of India, Puducherry ranks as the 29th most populous and the
3rd most densely populated city, with a population size of 946,600, spanning over 112 square
miles.
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Figure 4.1. The union territory of Puducherry is composed of 4 unconnected
districts (in red).

The district has a population density of 3,231 inhabitants per square kilometer, or 8,370
inhabitants per square mile, with a sex ratio of 1,031 females for every 1,000 males. The official
language used region-wide is Tamil and the literacy rate is 86.13%. All four districts are located
in the coastal region. Furthermore, there are seven rivers that run through the Karaikal district
and drain to the sea. In Puducherry, there is a total of 45 km of coastline and 675 km of inshore
coast available, which promotes an active fishermen population that has formed 27 marine
fishing villages and 23 inland fishing villages.
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Figure 4.2. Asommet Thirunallar temple in Karaikal

Puducherry draws tourists from all over the world due to its mosques, churches,
monuments and parks. The Karaikal region itself hosts 4 temples (Figure 4.2.), which
contributes to the spiritual principles held by its inhabitants (Karaikal District, 2019).
4.3. Statistical Analysis
1. For statistical analysis of genotype distributions and allele frequencies of RFC1 80 GA and
MTHFR 677 CT we used chi-square test for 2x2 table and chi-square test for contingency
tables. Significance level 0.05 was used.
2. For calculation of Hardy-Weinberg (HW) equilibrium in cleft samples and subsamples, and
in controls we followed this procedure:
a. Determine observed frequencies of two alleles of a gene in a sample
b. Calculate p and q (p + q=1)
c. Determine observed frequencies of genotypes in a sample
d. Calculate expected frequencies of genotypes for a sample using HW equation.
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e. HW equation is p2 + 2pq + q2 = 1
f. Compare observed and expected frequencies by Chi2 test (contingency table)
g. If difference is statistically non-significant, the alleles and genotypes in a sample are
in HW equilibrium and the sample data can be used for further analysis.
h. If difference is statistically significant (P < 0.05), the sample is unsuitable for further
analysis
i. Our degrees of freedom d.f.=1
3. For determinations of the comparative risk of having mutated allele (s) in combined
genotypes, Odd Ratio with 95% Confidence Interval was calculated for controls and subtypes
of clefts.
We consider as "exposure" a mutated allele in genotype of an individual (case or control) as
this is what he/she was born with and was exposed to an effect of mutated allele(s). The
“outcome” was a cleft (Table 4.2.). We tested mutated and wild alleles observed in
individuals with the same genotype in controls and cleft subgroups.

Table 4.2.
Template for calculation of Odds Ratio.
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CHAPTER 5

RESULTS

5.1. Polymorphism of RFC1 80 GA gene in cases and controls
Altogether 164 controls and 229 cases of CL±P were available for RFC1 80 GA genotype and
allele evaluation.
5.1.1. RFC1 80 GA Genotypes
In cases, 90 (39.3%) of the individuals had GG genotype, 30 (13.1%) had AA genotype, and 109
(47.6%) had AG genotype. In controls, 66 (40.24%) of the individuals had GG genotype, 22
(13.42%) had AA genotype, and 76 (46.34%) had AG genotype.

Table 5.1.
Distributions of RFC 80 GA genotypes in cases and controls.

Proportions of genotypes at nucleotide 80 of RFC1 gene in cases and controls are summarized in
Table 5.1. No statistically significant difference was found in genotype distribution between
cases (all types of clefts) and controls.
In subsamples by cleft type, we looked at distribution of RFC1 genotypes by sex of the patient.
In a detailed analysis, we tested differences in proportions of genotypes between different types
of clefts. There were some differences seen (Figure 5.1.), for example high proportion of
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homozygotes with mutated allele A in the cleft palate subsample. However, no statistically
significant difference was found.
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Figure 5.1. Chart comparing proportions of RFC1 80GA genotypes in controls
and in subgroups of clefts.

Table 5.2.
Comparison of RFC1 80 GA genotypes in controls and in different types of clefts.
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Last, we compared genotype distributions in different types of clefts and in subgroups of clefts
by sex of the patients. Also, no statistically significant differences were found (Table 5.2.).
5.1.2. RFC1 80 GA Alleles
The results for G and A allele frequencies and comparisons between cases and controls are
shown in Table 5.3.

Table 5.3.
Frequencies of A and G alleles in cases and controls.

The A allele frequency was 36.9% for cases and 36.59% for controls, and the G allele frequency
was 63.1% for cases and 64.41% for controls. As seen in Table 5.3., when lumping all type of
clefts together, the allele frequencies were practically same.
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Figure 5.2. RFC1 80 GA alleles G and A frequencies in controls and different types of clefts.
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For the detailed χ2 analysis of allele frequencies by cleft type, we used the same subgroups as
previously for genotype distributions (Table 5.4.). There was no significant difference found in
any of compared subsamples.

Table 5.4.
Comparison of RFC1 80GA alleles G and A in controls and in different types of clefts.
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5.2. Polymorphism of MTHFR 677 CT gene in cases and controls
For analysis of MTHFR polymorphism we had 153 genotypes from controls and 179 from all
types of cleft patients (cases). Compared to specimens available for RFC1, we had less controls
and more cases.
5.2.1. MTHFR 677 CT Genotypes
It both samples – cases and controls, he observed the high proportion of CC genotypes: controls
81.05% (124 individuals); cases 83.8% (150 individuals). It was interesting that we didn’t
observe any mutated homozygote in control sample. There were only 3 individuals (1.67%)
among cleft patients. Heterozygotes differed just a little bit: controls 18.95% (29 individuals) and
cases 14.53% (26 individuals).
Proportions of MTHFR 677 CT genotypes in cases and controls are summarized in Table 5.5.

Table 5.5.
Distribution of MTHFR 677 CT genotypes in cases and controls.

We can see that all three TT homozygotes (both mutated alleles) were observed in CL unilateral.
These patients had left side CL – two of them were males and one female.
As there were no mutated homozygotes TT in controls and in cases, only in CL uni subgroup, we
didn’t do any more evaluation of MTHFR 677 CT genotypes.
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Figure 5.3. Chart comparing proportions of MTHFR 677 CT genotypes
in controls and in subgroups of clefts.

5.2.2. MTHFR 677 CT Alleles
Also allele frequencies didn’t differ when controls and sample of all clefts were compared (Table
5.6.).

Table 5.6.
Frequencies of C and T alleles in cases and controls.

Similar as in RFC1, we also observed differences in allele frequencies (Figure 5.4.), but
also not statistically significant.
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Figure 5.4. C and T alleles of MTHFR 677 CT gene in controls and in subgroups of clefts.

Then, the detailed χ2 analysis of allele frequencies by cleft type compared to controls was
performed. There was no significant difference found in any of compared subsamples (Table 5.7.).

Table 5.7.
Comparison of RFC1 80GA alleles G and A in controls and in different types of clefts.
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5.3 Combined genotypes of RFC1 80AG + MTHFR 677 CT+ IRF6 rs642961 + IRF6
rs2235371 in categories by types of clefts and in controls
In this study, the control sample had 140 individuals (74 males and 66 females) and the case
sample 177 individuals (95 males and 82 females) with all four genes genotyped. Thus, those
were used for analysis of combined genotypes.
There are three possible combinations of alleles for each gene studied (wild homozygote with
both no mutated (wild) allele, heterozygote with one wild allele and one mutated allele, and
homozygote with both mutated alleles). Thus, two genotype combinations will lead to 9
combined genotypes, three genotypes combinations will lead to 27 combined genotypes and 4
genotype combinations will lead to 81 combined genotypes.
Thus, as mentioned in Material and Methods section, there are 81 possible combinations of
RFC1 80GA + MTHFR 677CT+ IRF6 rs642961 + IRF6 rs2235371 (Figure 5.5.).

Figure 5.5. All possible combination of genotypes of RFC1 80GA, MTHFR 677CT, IRF6 rs642961,
and IRF6 rs223531 leading to combined genotype of these four genes.
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However, not all combinations were detected in our study. In the control group 25 and in the
case group 28 of these combinations were observed. For better presentation, we used color
coding of genotypes with mutated alleles (Table 5.8).
While lumping together some unique combined genotypes would increase a size of a subsample,
it may as well mask associations with a specific type of cleft. Thus, we tried to avoid it as much
as possible.

Table 5.8.
Combined genotypes of RFC1 80GA (yellow), MTHFR 677CT (green), IRF6 rs642961 (orange),
and IRF6 rs223531 (blue) in cases and controls in our study.
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5.3.1 Testing Hardy Weinberg equilibrium in categories by type of clefts and in controls
The Hardy-Weinberg law (Hardy-Weinberg equilibrium) is the basis of population genetics.
It states that in a large random-mating population at equilibrium (in absence of selection,
migration or genetic drift) genotype frequencies are functions of allele frequencies. Genotype
frequencies can be predicted from the allele frequencies.

Hardy-Weinberg equilibrium is defined by the following equation

p2 + 2pq + q2 = 1,

where p and q are allele frequencies and p2 , 2pq and q2 represent frequencies of major allele
homozygotes, heterozygotes and minor allele homozygotes in a population, respectively.

Presence of the Hardy-Weinberg equilibrium is typically assessed by Chi square test.
Resulting P value P > 0.05 confirms null hypothesis, which states that a tested population is in
equilibrium.
Values of P<0.05 mean that there is a violation of Hardy-Weinberg law assumptions. They may
be caused by biased collection of individuals in a sample, by incorrect genotyping and other
errors.
Our results are summarized in the Table 5.8.
For all our samples, controls and cases, agreement with Hardy-Weinberg equilibrium was
confirmed showing that further analyses and comparisons can be applied.
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Table 5.9.
Hardy Weinberg equilibrium calculations for subgroups of clefts and controls.
Calculation for IRF6 rs2235371 is in process, additional data are needed.

5.3. 2. Odds Ratio and Confidence Interval (95% significance level)
5.3.2.1. One mutated gene allele in a combined genotype
In control sample, we observed 52 individuals (out of 140) with one mutated allele in
combined genotype (28 with mutated allele “A” in RFC1 80 GA, 5 with mutated allele “T” in
MTHFR 677 CT gene, 15 with mutated allele “a” in IRF6 rs642961 gene, and 4 with mutated
allele “t” in IRF6 rs2235371 gene. In cases, there were 82 of those out of 177 (49 with mutated
allele “A” in RFC1 80 GA, 8 with mutated allele “T” in MTHFR 677 CT gene, 17 with mutated
allele “a” in IRF6 rs642961 gene, and 8 with mutated allele “t” in IRF6 rs2235371 gene (Table
5.7).
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Mutated and wild alleles in each subgroup of clefts and corresponding Odds Ratio are
presented in Table 5.10.

Table 5.10.
Odds Ratio for combined genotypes with one mutated allele
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While genotypes with RFC1 mutated allele were observed in all five cleft subgroups (CL
uni, CL bi CLP uni, CLP bi, and CP), no genotype with mutated allele in any of IRF6 variants
was observed in CL bi, and no mutated allele of MTHFR was seen in CL bi and CP.
Comparison of Odds Ratios between controls and different types of clefts is presented in
Figure 5.6.

Figure 5.6. Odds ratio and CI for combined genotypes with one mutated allele.

5.3.2.2. Two mutated gene alleles in a combined genotype
Combined genotypes with mutated alleles from two different genes were most common in
our study. There were altogether 54 of those in controls and 57 in cases. The most common
combination in controls as well as in cases was the genotype with a mutation in RCF1 80 GA
and IRF6 rs642961 variant (Table 5.7.).
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Only genotypes with mutations in RFC1 and IRF6 rs642961 were observed in all subgroups
of clefts (Table 5.11.).

Table 5.11.
Odds Ratio for combined genotypes with two mutated alleles
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In the CP subgroup, no genotypes with mutations in RFC1 + MTHFR, MTHFR + IRF6
rs642961, and both variants of IRF6 were observed. In CL bi, no genotypes with mutations in
RFC1 + IRF6 rs2235371, MTHFR + IRF6 rs642961, and both variants of IRF6 were
observed.
Odds ratio for comparisons with controls are presented on Figure 5.7. Only genotypes with
mutated alleles in RFC1 + MTHFR in CL uni and RFC1 + IRF6 rs2235371 in CP showed
OR numbers over 1.
There was only one combined genotype for CP observed, so this is not a valuable result.
However in CL unilateral, there were four males with this genotype.

Figure 5.7. Odds ratio and CI for combined genotypes with two mutated alleles.
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5.3.2.3 Three mutated gene alleles in a combined genotype
Genotypes with three genes with mutated alleles occurred in 9 individuals in controls and in
8 individuals in cases. No mutations in three genes were observed in CL bi and CLP bi (Table
5.12.). In general, these genotypes were rare in both cases and controls.

Table 5.12.
Odds Ratio for combined genotypes with three mutated alleles

Odds Ratios for comparisons with controls are presented on Figure 5.8. While we see some
fluctuation around 1, we have to be careful with a wider extrapolation of these findings, because
the numbers in some of these categories are small.
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Again CL uni seems to show interesting results for mutations in RFC1+MTHFR+ IRF6
rs2235371. While in the controls, this genotype was observed in 4.3% of all individuals, in cases
in 0.3%, and that is the only one CL uni case.

Figure 5.8. Odds ratio and CI for combined genotypes with three mutated alleles.

5.4. Proportion of combined genotypes with mutated alleles in all four genes and combined
genotypes with no mutations in cases and in controls
We observed only one individual with mutations in all four genes in the case sample. She
was a female with a unilateral cleft lip.
There was no combined genotype with all mutated genes found in the control sample.
There were altogether 25 individuals (17.86%) in the control sample with no mutations in
any of these four genes studied (11 males and 14 females). A slightly lower proportion was
found in cases- 28 individuals - 15.82 %. (Table 5.13.).
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Table 5.13.
Combined genotypes with no mutations in cases and controls

When each subgroup was evaluated separately, only one genotype with no mutated alleles was
found in CP (6.25%). We only had 6 cases with the subgroup of bilateral CL. Out of them one
female was observed with no mutations (Figure 5.9). In other subgroups by type of cleft, the
proportions were very similar.

Figure 5.9. Comparison of proportions of genotypes with no mutations in subgroups of clefts
and controls.
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CHAPTER 6

6.1. DISCUSSION
Our results suggest that combinations of gene polymorphisms may modulate genetic risk in
subtypes of nonsyndromic orofacial clefts. As seen in Table 5.14., some combinations of RFC1
80 GA, MTHFR 677 CT, IRF6 rs642961 and IRF6 rs2235371 yielded increased or decreased
Odds Ratio. This is an interesting finding that would deserve further investigation.

Table 5.14.
Gene combinations that showed increased or decreased OR values in subtypes of orofacial clefts
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For the same combination of genotypes, we have compared the numbers of alleles in cleft
subsample and controls. Increased OR>1 value would mean an increased genetic risk for
individuals with those genotypic combinations. Similarly, decreased OR<1 value would mean a
decreased genetic risk for individuals with those genotypic combinations. It may be significant
for genetic counseling and prevention measures in the studied location.
Among cases, the unilateral cleft lip occurred in the high proportion (Table 4.1.). Also, an Odds
Ratio of OR>1 occurred most often in this subtype. On the other side, the number of unilateral
cleft cases without any mutated allele in the four studied genes was almost the same with
identical genotypes in controls (Table 5.13.). There were other genes and factors that led to the
development of those clefts. However, building on this genetic background, specific
combinations of four gene polymorphisms (containing mutated alleles) led to differential
occurrences of unilateral cleft and increase of genetic risk. Is it possible that a change of balances
in a genetic network may play a role?
Association of candidate genes with nonsyndromic orofacial clefts has been studied for
individual gene polymorphisms or for combinations of two gene polymorphisms. It is well
known that facial development and etiology of orofacial clefts involves a number of genes (more
than 25 have been identified) connected in a gene network. This means that when studying one
or a few genes we are dealing with an unidentified effect of other genes in a network. We have
gotten the results for combinations of four genes. However, the number of genes studied in
combinations needs to be increased to extend and complement our results.
We have focused on the genetic part of etiology of orofacial clefts. However, environmental
factors constitute a major proportion in etiology of nonsyndromic orofacial clefts. This is another
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non-quantified factor in our study. Studying cases and controls who were living in the same
location at the same time, helped to normalize this factor.
Although a nature of gene interactions in etiology of orofacial clefts is largely not known, our
results suggest their existence. In our study, we compared folate metabolism genes with IRF6
gene polymorphisms. RFC1 and MTHFR regulate the supply of active folate for cell metabolism
– their effect is indirect, mediated by folate. IRF6 rs642961 and rs2235371 gene polymorphisms
code for transcription factors influencing expression of other genes directly by binding to DNA
sites. Interestingly, we have found that their combinations changed OR values in subgroups of
non-syndromic orofacial clefts.
Typically, the test for Hardy-Weinberg equilibrium is run for control groups. In groups of cases,
deviations from the Hardy-Weinberg law may occur, because their selection was non-random based on a certain phenotype. Still, confirmation of agreement with Hardy-Weinberg law
supports absence of bias, for example, due to stratification of a sample of cases.
The limitations of our study are in the small size of our sample and a low number of studied
gene polymorphisms. Further studies involving a larger sample and more gene polymorphism
combinations are needed, in order to obtain more genotype combinations in sufficient quantities.
Additionally, more can be learned from analysis of proband-mother duos or proband-motherfather trios. Available data exists in our database. On a cellular level, gene expression is also
controlled by epigenetic mechanisms (methylation of DNA, miRNA’s). These features need to
be analyzed as well.
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Initially, we have asked a question: Do cleft phenotypic subgroups have a different multigenic
component (out of four studied gene polymorphisms) in the background? Results of our analysis
support a positive answer. Our null hypothesis was rejected.
This kind of study seems to be important for the development of a general procedure how a
prevention plan for a specific location needs to be prepared, which data need to be collected and
which analyses need to be performed.

6.2. CONCLUSIONS
A large dataset of cases and controls collected in one location (Karaikal in India) and
genotyped for four gene polymorphisms: RFC1 G80A, MTHFR C677T, IRF6 GA rs642961 and
IRF6 CT rs2235371 (IRB approval Nr. 17-118 for existing data) was analyzed.
The Hardy-Weinberg equilibrium test showed that all samples were in genetic equilibrium.
Some combinations of RFC1 G80A, MTHFR C677T, IRF6 GA rs642961 and IRF6 CT
rs2235371 yielded increased or decreased Odds Ratio (OR>1 or OR<1). This means that the
subtypes of orofacial clefts were differentially determined by genotype combinations of four
gene polymorphisms.
Our results suggest that combinations of gene polymorphisms may modulate genetic risk in
subtypes of nonsyndromic orofacial clefts. Such studies seem to be important for the
development of a general procedure of how a prevention plan for a specific location needs to be
prepared, which data need to be collected and which analyses need to be performed.
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